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Summary
Genomewide linkage studies of type 1 diabetes (or in-
sulin-dependent diabetes mellitus [IDDM]) indicate that
several unlinked susceptibility loci can explain the clus-
tering of the disease in families. One such locus has been
mapped to chromosome 11q13 (IDDM4). In the present
report we have analyzed 707 affected sib pairs, obtaining
a peak multipoint maximum LOD score (MLS) of 2.7
( ) with linkage ( ) extending over al  1.09 MLS x 0.7s
15-cM region. The problem is, therefore, to fine map
the locus to permit structural analysis of positional can-
didate genes. In a two-stage approach, we first scanned
the 15-cM linked region for increased or decreased trans-
mission, from heterozygous parents to affected siblings
in 340 families, of the three most common alleles of
each of 12 microsatellite loci. One of the 36 alleles
showed decreased transmission (50% expected, 45.1%
observed [ , corrected ]) at markerP  .02 P  .72
D11S1917.Analysis of an additional 1,702 families pro-
vided further support for negative transmission (48%)
of D11S1917 allele 3 to affected offspring and positive
transmission (55%) to unaffected siblings (test of het-
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erogeneity , corrected ]). A second4P  3# 10 P  .01
polymorphic marker, H0570polyA, was isolated from a
cosmid clone containing D11S1917, and genotyping of
2,042 families revealed strong linkage disequilibriumbe-
tween the two markers (15 kb apart), with a specific
haplotype, D11S1917*03-H0570polyA*02, showing
decreased transmission (46.4%) to affected offspring
and increased transmission (56.6%) to unaffected sib-
lings (test of heterogeneity , corrected6P  1.5# 10
). These results not only provide suffi-4P  4.3# 10
cient justification for analysis of the gene content of the
D11S1917 region for positional candidates but also
show that, in the mapping of genes for common mul-
tifactorial diseases, analysis of both affected and unaf-
fected siblings is of value and that both predisposing and
nonpredisposing alleles should be anticipated.
Introduction
Type 1 diabetes is a common multifactorial disease re-
sulting from an interaction of many genes and, probably,
of many environmental factors, resulting in the specific
immune-mediated destruction of the insulin-producing
cells of the pancreas and in life-long insulin deficiency
(Tisch and McDevitt 1996). Functional candidate-gene
analyses based on case-control association studies and,
later, on family-based studies have led to the identifi-
cation of two IDDM loci: (1) IDDM1 on chromosome
6p21, which, in part, most likely corresponds to func-
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Table 1
Sources and Numbers of Multiplex and Simplex Families,
according to Stage of Analysis
Analysis and Family Data Set No. of Families
Initial linkage study:
U.K. multiplex 236
U.S. multiplex 104
Total 340
Follow-up linkage study:
U.K. multiplex 165
U.S. multiplex 133
Norwegian multiplex 31
Continental Italy multiplex 38
Total 367
Initial scan for association:
U.K. multiplex 236
U.S. multiplex 104
Total 340
Follow-up association study:
U.K. multiplex 165
U.S. multiplex 133
Norwegian multiplex 31
Continental Italy multiplex 38
U.K. simplex:
Yorkshire 80
Southwest 32
Age !5 years at diagnosis 56
St. Bart’s-Oxford Family Study 24
Sardinian:
Simplex 175
Multiplex 6
Norwegian simplex 375
Continental Italian simplex 62
Finnish simplex 216
Romanian simplex 204
Danish simplex 105
Total 1,702
tional amino acid variation in the peptide-binding sites
of the T lymphocyte antigen–recognition molecules
MHC HLA-DR and -DQ (Cucca and Todd 1996; She
1996; Thorsby and Undlien 1996), and (2) IDDM2 on
chromosome 11p15, corresponding to polymorphism of
a VNTR locus in the promoter of the insulin gene (INS),
which affects transcription of INS (Bennett et al. 1995;
Vafiadis et al. 1997). However, until recently (Nistico` et
al. 1996), candidate-gene studies have provided little ad-
ditional insight into inheritance of type 1 diabetes, since
1984, when the association of the INS VNTR with the
disease was first discovered (Bell et al. 1984). With im-
provements in technology and genetic maps (Reed et al.
1994), encouraging gene-mapping results from the spon-
taneous mouse model of type 1 diabetes (Todd et al.
1991; Wicker et al. 1994) and from collections of large
numbers of multiplex families (Bain et al. 1990; Lern-
mark et al. 1990), it became possible to embark on sys-
tematic searches of the whole human genome, for chro-
mosome regions showing evidence of linkage to disease.
The first scans showed that IDDM1/MHC on chro-
mosome 6p21 was the major locus, contributing X50%
of the familial clustering of the disease ( , the ratiol  3s
of the expected proportion of affected sib pairs sharing
zero alleles identical by descent [IBD], .25, and the ob-
served proportion) (Davies et al. 1994; Hashimoto et al.
1994), with a more modest contribution, !10%, from
IDDM2 ( ) (Davies et al. 1994). These studiesl  1.25s
and a candidate-gene study (Field et al. 1994) also pro-
vided some positive evidence for other loci, particularly
a locus on chromosome 11q13, designated “IDDM4.”
On the basis of evidence of linkage in several affected-
sib-pair data sets studied in at least four independent
laboratories, support for the existence of IDDM4 has
been extended, to (Luo et al. 1996), and6P  1.5# 10
it now appears highly likely that a type 1 diabetes gene(s)
is encoded by chromosome 11q13.
The problem now is to fine map loci such as IDDM4
that have modest effects ( ) within broad regionsl ! 1.3s
of linkage. We have advocated (Copeman et al. 1995)
using the transmission/disequilibrium test (TDT) (Spiel-
man et al. 1993) to search for evidence of association
in regions for which there is prior evidence of linkage,
because it should provide a finer localization of the dis-
ease locus and is a more powerful way of detecting ef-
fects, owing to the selected analysis of parents hetero-
zygous for test alleles. Families with only one affected
sibling can also be used in TDT. However, association
mapping is problematic because the association of a
chromosome region is dependent on the unknown dis-
tribution of the alleles of the markers on predisposing
and nonpredisposing chromosomes. We have begun to
investigate the application of association mapping in the
common, multifactorial disease type 1 diabetes, using
data from chromosome 18q21 (the putative locus
IDDM6) (Merriman et al. 1997, 1998) and, in the pre-
sent study, data from chromosome 11q13/IDDM4. We
report evidence of association of the D11S1917 region
with type 1 diabetes. This result has led to the identi-
fication of a new member of the LDL-receptor family,
close toD11S1917,which is a functional candidate gene
for type 1 diabetes (Hey et al., in press). Moreover, we
demonstrate both the utility of analyzing both affected
and unaffected offspring and the importance of consid-
ering both positively and negatively transmitted marker
alleles and haplotypes.
Subject and Methods
Diabetic Families
All families in this study were Caucasian, and, in each
family, at least one affected sibling and both parentswere
included (table 1). The U.K. data set consisted of 401
multiplex families, 80 simplex families from the York-
shire region, and 32 simplex families from the south-
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western region (all three groups have been described else-
where [Merriman et al. 1997, 1998], 56 simplex families
in which all cases had been diagnosed at age !5 years
(Wadsworth et al. 1995), and 24 simplex families from
the Bart’s-Oxford Family Study/Oxford Regional Pro-
spective Study with cases that had been diagnosed at age
!21 years (Gardner et al. 1997). The 237 U.S. affected-
sib-pair families were obtained from the Human Bio-
logical Database Interchange (Lernmark et al. 1990),
and each had at least one affected sibling that had been
diagnosed at age !29 years. The 181 Sardinian families
(175 simplex and 6 multiplex), 406 Norwegian families
(375 simplex and 31 multiplex), and the 100 continental
Italian families (62 simplex families and 38 multiplex
families) have been described elsewhere (Merriman et al.
1997, 1998). The Finnish data set comprised 216 sim-
plex families in which all cases had been diagnosed at
age !15 years (Tuomilehto et al. 1992), and the Ro-
manian data set comprised 204 simplex families inwhich
all cases had been diagnosed at age !30 years. The 105
Danish simplex families have been described elsewhere
(Pociot et al. 1993). Unaffected siblings were collected
when it was possible to do so.
Physical Mapping and Genotyping
Cosmid H0570 was isolated from a gridded flow-
sorted chromosome 11–specific library (Nizetic et al.
1994). We attempted to isolate dinucleotide repeats
from this clone, according to the method described else-
where (Copeman et al. 1995). A clone that seemed to
be positively hybridized with a (CA)n dinucleotide
probe was sequenced. This clone did not contain dinu-
cleotide repeats but, instead, contained a mononucle-
otide (A)n repeat for which PCR primers were designed:
H0570polyA forward (5′- TTT CCT CTC TGG GAG
TCT CT-3′) and reverse (5′-GGA CAG TCA GTT ATT
GAA ATG-3′). Intermarker distance was elucidated by
standard restriction enzyme–mapping techniques, and
the orientation was determined by examination of the
genotypes of multiplex families in which a recombina-
tion had occurred within the contig of cosmid clones,
including H0570, analyzed elsewhere (Courseaux et al.
1997). Genotyping PCRs using fluorescently labeled
primers were performed and analyzed as described else-
where (Reed et al. 1994).
Analysis of Linkage and Allelic Association
Multipoint LOD score (MLS) values were calculated
by the MAPMAKER/SIBS program (Kruglyak and
Lander 1995). The P values assigned to MLSs were the-
oretical (Holmans 1993). Transmission, from hetero-
zygous parents to both affected and unaffected offspring,
of single microsatellite marker alleles and of two marker
haplotypes was assessed by TDT (Spielman et al. 1993),
and statistical support for allelic association was deter-
mined by the Tsp statistic, in which all affected siblings
are included in the analysis (Martin et al. 1997). The
extent of linkage disequilibrium of an allele or haplotype
with disease was quantitated in terms of percentage of
transmission, which is the number of times that an allele
is transmitted from heterozygous parents to affected and
unaffected children, divided by the total number of
transmissions, expressed as a percentage. Haplotypes
could not be constructed definitely in 161 families, be-
cause of F1 intercross status. In these families, the most
likely haplotypes were determined on the basis of tight
linkage disequilibrium between the two markers,
D11S1917 and H0570polyA. D′ values were calculated
as described elsewhere (Devlin and Risch 1995).
Results
Linkage Mapping
All the multiplex type 1 diabetic families available in
our previous study (Davies et al. 1994) ( [236n  340
U.K. families and 104 U.S. families]) have been geno-
typed for 18 microsatellite markers in 25 cM of chro-
mosome 11q13 (fig. 1A). Peak evidence of linkage by
multipoint analysis was obtained at the marker
D11S1883 ( ; ; ). A furtherMLS  1.26 P  .01 l  1.09s
367 multiplex families subsequently became available,
and multipoint linkage of chromosome 11q13 was eval-
uated by use of all 18 markers (fig. 1B), providing ad-
ditional support for IDDM4, with peak linkage at
D11S1337, in the total of 707 families ( ;MLS  2.7
; ) (fig. 1C). In our original study,P  .0003 l  1.09s
we had detected IDDM4 by conditioning the linkage at
the chromosome 11q13 marker locus FGF3 by means
of the allele-sharing status at the IDDM1/MHC locus
in 282 families (Davies et al. 1994). In the 640 families
(of 707) for which IDDM1 typing was available, peak
linkage was atD11S1337 ( ), and most of theMLS  2.9
support for linkage still came from the families (n 
) in which sib pairs shared one or zero IDDM1/294
MHC haplotypes IBD (peak at FGF3, 3 cM distal to
D11S1337 [ ]), compared with the remainingMLS  2.6
families ( ), in which sib pairs shared two allelesn  346
IBD at IDDM1 (at FGF3 [ ]). In neither theMLS  .6
present study nor the previous study (Davies et al. 1994)
was there significant evidence for heterogeneity between
categories ( ).P 1 .05
Given recent interest in discordant sib-pair linkage
mapping (Risch and Zhang 1995), we evaluated evi-
dence of linkage in discordant affected-unaffected pairs
of siblings, compared with evidence from the same type
of analysis in affected pairs (table 2). There was no sta-
tistically significant support for IDDM4 in the discor-
Figure 1 Multipoint linkage analysis of chromosome 11q13 in type 1 diabetic affected-sib-pair families
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Table 2
Linkage of Chromosome 11q13 to Type 1 Diabetes in Discordant
and Concordant Sib Pairs
DATA SET
NO. (%) OF SIB PAIRS
SHARING OR NOT SHARING
ALLELE IBDa
One Allele No Alleles Pb
Unaffected-affected pairs:
United Kingdom 46 (47.42) 51
United States 32 (48.5) 34
Sardinia 129 (45.9) 152
U.K. simplex 64 (46.7) 73
Romania 151 (57.0) 114 .02
Finland 64 (45.7) 76
Denmark 52 (50.5) 51
Italy 46 (50) 50
Total 584 (49.3) 601
Affected pairs:
United Kingdom 391 (52.0) 361
United States 263 (56.0) 207 .01
Norway 28 (54.9) 23
Italy 62 (60.1) 40 .03
Total 744 (54.1) 631 .002
a Data were obtained by combining of results from both marker
D11S1917 and H0570polyA.
b Calculated from x2 test of allele sharing, against an expected ratio
of 1:1 (only values X.05 are shown).
dant pairs, although six of eight data sets showed that
IBD sharing of alleles was !50%.
TDT of the D11S1917 Region
The three most common alleles of 12 of these markers
(D11S1908, D11S480, D11S1883, D11S913, PPP1A,
D11S987, D11S1296, D11S1917, D11S1337, FGF3,
D11S971, and D11S1314; each with maximum
) were analyzed by TDT in 340 families (236MLS x .7
U.K. families and 104 U.S. families). Of the 36 alleles
tested, only allele 3 of D11S1917 showed transmission
from heterozygous parents to affected children that was
different from the expected 50%: there were 247
(45.1%) cases of transmission and 301 cases of no trans-
mission ( , corrected ).P  .02 P  .72
The transmission of allele 3 of D11S1917 then was
analyzed in all 2,042 families, extending support to
in the comparison of transmission to af-4P  3# 10
fected offspring versus transmission to unaffected off-
spring (table 3; 48% and 55% transmission, respec-
tively). We derived a second polymorphic marker from
a D11S1917-positive cosmid, H0570 (Courseaux et al.
1997), a mononucleotide microsatellite repeat, (A)n,
named “H0570polyA.” Allele 2 of the H0570polyA lo-
cus showed strong linkage disequilibrium with allele 3
of D11S1917 ( ; ); hence the′ 100D  .94 P X 1# 10
transmission of allele 2 of H0570polyA was evaluated
specifically in the 2,042 families (table 4). Marker
H0570polyA was more strongly associated with type 1
diabetes than was D11S1917: 46.7% transmission of
allele 2 to affected siblings (TDT and TspP  .003
) and 54.7% transmission of allele 2 to unaf-P  .004
fected siblings ( ), with a significant test of het-P  .004
erogeneity ( ). The D11S1917*03-5P  4.8# 10
H0570polyA*02 (3-2) haplotype also was associated
with type 1 diabetes (Tsp ). The transmission ofP  .002
the 3-2 haplotype also was significantly different be-
tween affected and unaffected siblings (heterogeneity
; table 4). Correction of this P value by6P  1.5# 10
the number of loci and alleles tested ( ) and byn  36
the number of data sets analyzed ( ) givesn  8 P 
and , respectively.5 45.4# 10 P  4.3# 10
Having obtained substantial support for an associa-
tion of the D11S1917-H0570polyA region with type 1
diabetes and having identified a nonpredisposing hap-
lotype, we evaluated the transmission of the other com-
mon haplotypes of these markers, in the expectation that
one or more of them should have 150% transmission
to affected siblings and perhaps !50% transmission to
unaffected siblings (table 5). Five haplotypes represented
97.3% of all haplotypes in the families: 3-2 (26.6% fre-
quency in all children of 2,012 families; ), 2-3′D  .94
(28.6%; ; ), 2-1 (20.7%;′ 20 ′D  .12 P ! 1.4# 10 D 
; ), 1-3 (20.1%; ;100 ′.61 P ! 1# 10 D  .6 P ! 1#
), and 3-3 (1.95%; ; ).100 ′ 10010 D  .63 P ! 1# 10
Three of these haplotypes—2-3, 2-1, and 1-3—were
slightly positively transmitted to affected siblings, at fre-
quencies of 51.3%, 51.9%, and 51.6%, respectively, and
were slightly negatively transmitted to unaffected sib-
lings, at frequencies of 46.3% ( ), 49.0%, andP  .04
49.0%, respectively. This pattern of transmission ap-
pears to be compensatory for that of the 3-2 haplotype,
which has the opposite pattern. The fourth haplotype,
3-3, although much rarer than the others, provided in-
teresting results suggesting that it is being positively
transmitted more often than are the other three haplo-
types, with 62.4% ( ) transmission to affectedP  .001
siblings and 42.6% transmission to unaffected siblings
(test of heterogeneity between transmission to affected
and transmission to unaffected siblings, ). TheP  .008
62.4% transmission of the 3-3 haplotype was signifi-
cantly different from the average 51.6% transmission of
the 2-3, 2-1 and 1-3 haplotypes combined (x2 test of
heterogeneity, ).P  .006
Discussion
In the largest linkage study of the chromosome 11q13
region in type 1 diabetes to date, we have obtained in
707 affected-sib-pair families a peakMLS of 2.7 (marker
D11S1337; ) and a peak ls of 1.09. This com-P  .0003
pares with the results of a previous study of 596 affected-
sib-pair families, which produced at markerMLS  5.0
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Table 3
Transmission of Allele 3 of D11S1917 to Affected and Unaffected Offspring in
2,042 Type 1 Diabetic Families
NO. (%) OF FAMILIESa
Pb HET Pc
Affected Offspring Unaffected Offspring
T NT T NT
United Kingdom 373 (47.2) 417 75 (55.1) 61
United States 174 (48.3) 186 33 (57.9) 24
Norway 151 (48.2) 162 158 (53.6) 137
Sardinia 62 (48.4) 66 55 (62.5) 33 .02 .04
Romania 93 (52.8) 83 67 (51.9) 62
Finland 68 (46.6) 78 37 (49.3) 38
Italy 51 (41.8) 71 46 (61.3) 29 .05
Denmark 42 (52.5) 38 47 (54.7) 39
Total 1,014 (47.9) 1,101 518 (55) 423 .002 .0003
a T  transmission; NT  no transmission; and Het P  heterogeneity P.
b From TDT using all affected sibs (only values X.05 are shown).
c From contingency-table heterogeneity test of data for affected offspring2# 2
versus data for unaffected offspring (only values X.05 are shown).
D11S1296 (100 kb centromeric of D11S1337; authors’
unpublished data) (Luo et al. 1996). That study included
data from 331 U.K., U.S., and French families reported
in prior studies (Davies et al. 1994; Hashimoto et al.
1994), and these U.K. and U.S. families are included
within the 707-family data set of the present study. For
the D11S1917 region in the 707 families analyzed here,
the number of cases in which one and zero alleles were
shared IBD were 744 (54.1%) and 631, respectively. If
we add the corresponding results for the French families,
173 and 128 (Hashimoto et al. 1994), then the total
at 54.7% IBD sharing (by the formu-MLS  3.2
la ,MLS  N [log (N /0.5N)]N [log (N /0.5/N )]1 10 1 0 10 0 0
where N1 and N0 are the number of sib pairs sharing
one and zero alleles IBD, respectively, and N  N 1
). These data, combined with the TDT results (tablesN0
4 and 5), strongly support the existence of IDDM4
within 11q13, but the effect at is modest, andl  1.09s
the average odds ratio for the etiological, predisposing
allele, when it is eventually identified, cannot be 11.5 in
this total sample. Moreover, this assumes that the linked
region contains only one disease locus, which is not what
we are finding in genetic analysis of type 1 diabetes in
inbred strains of mice (Podolin et al. 1997, 1998). It is
noted, however, that in certain ethnically homogeneous
populations, the ls value might be much greater, de-
pending on the allele frequencies at IDDM4 and at other
interacting loci and on the effects of unknown environ-
mental factors. Efforts must be made to collect very large
numbers of families (or cases and genetically matched
controls) from such homogeneous populations in which
the effect of a particular locus is exaggerated, to permit
detailed fine mapping and disease-gene identification.
The magnitude of effect obtained here by use of a mix-
ture of populations is, however, likely to be typical of
susceptibility genes responsible for the development of
type 1 diabetes and other common multifactorial
diseases.
In our analyses, the initial detection of IDDM4 was
dependent on conditioning of the linkage data for chro-
mosome 11q13 by the sharing status at IDDM1/MHC.
Although there is no significant heterogeneity, the bias
in linkage of chromosome 11q13 to disease when one
or zero alleles are shared at IDDM1/MHC is still ob-
served in 640 families. Our results suggest that, in the
initial detection of potentially interesting chromosome
regions, conditioning of marker data by the sharing
status at other unlinked loci is a worthwhile strategy.
We would not have continued to study the chromosome
11q13 region if we had not conditioned the data by
IDDM1.
We have found evidence for a common haplotype for
which the transmission to affected and unaffected sib-
lings is !50% and 150%, respectively, suggesting that
this haplotype contains an allele that is nonpredisposing
for or even protective against type 1 diabetes. In the
same way, the IDDM1MHC class II HLA-DQB1*0301
allele is negatively transmitted to affected siblings and
is protective against type 1 diabetes (F. Cucca and J. A.
Todd, unpublished data). In addition, a rare INS VNTR
class III haplotype shows a distinctive pattern of !50%
transmission to affected siblings (Bennett et al. 1995),
indicating its protective role with regard to disease.
For these markers in these families, the most powerful
statistic is a test of heterogeneity between the affected
and unaffected data sets, yielding in sup-6P  1.5# 10
port of a difference in transmission of the protective 3-
2 haplotype to affected versus unaffected offspring (table
Table 4
Transmission of H0570polyA Allele 2 and the D11S1917*03-H0570polyA*02 Haplotype to Affected and Unaffected Offspring in 2,042 Type 1 Diabetic Families
NO. (%) OF FAMILIES
Allele 2 D11S1917*03-H0570polyA*02 Haplotype
Affected Offspring Unaffected Offspring
Het P
Affected Offspring Unaffected Offspring
Het PT NT P T NT P T NT P T NT P
United Kingdom 356 (45.8) 421 .02 78 (56.1) 61 .02 327 (45.9) 386 .05 75 (57.3) 56 .02
United States 178 (46.6) 204 34 (54.0) 29 162 (47.0) 183 31 (57.4) 23
Norway 140 (48.6) 148 136 (51.7) 127 111 (47.8) 121 114 (54.0) 97
Sardinia 63 (47.0) 71 60 (61.2) 38 .03 .03 52 (45.6) 62 54 (65.9) 28 .004 .005
Romania 95 (53.7) 82 66 (53.2) 58 83 (51.2) 79 60 (54.1) 51
Finland 66 (45.2) 80 38 (49.4) 39 57 (44.5) 71 35 (50) 35
Italy 39 (36.4) 68 .005 42 (60.9) 27 37 (37.4) 62 37 (60.7) 24 .004
Denmark 40 (48.8) 42 51 (56.7) 39 35 (49.3) 36 42 (58.3) 30
Total 977 (46.7) 1,116 .003 505 (54.7) 418 .004 54.8# 10 864 (46.4) 1,000 .002 448 (56.6) 344 .0002 61.5# 10
NOTE.—See footnotes to table 3.
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Table 5
Transmission of Haplotypes 2-3, 2-1, 1-3 and 3-3 of Markers D11S1917 and H0570polyA in 2,042 Type 1 Diabetic Families
NO. (%) OF FAMILIES
United
Kingdom
United
States Sardinia Norway Romania Finland Italy Denmark Total
P
Het
PT NT T NT T NT T NT T NT T NT T NT T NT T NT
Affected:
2-3 376 348 187 176 65 71 123 105 65 69 69 63 37 45 37 35 959 (51.3) 912
2-1 278 267 126 117 71 54 87 85 69 71 55 52 52 42 38 31 776 (51.9) 719
1-3 276 235 146 138 33 37 106 105 40 50 75 74 43 25 24 32 743 (51.6) 696
3-3 37 31 30 18 4 1 11 6 2 1 9 3 6 0 7 4 106 (62.4) 64 .001
Unaffected:
2-3 58 68 20 38 48 52 104 123 43 46 37 40 23 25 40 40 373 (46.3) 432 .04 .02
2-1 52 47 21 23 43 52 85 80 49 47 29 31 15 25 34 36 328 (49.0) 341
1-3 44 55 18 16 25 27 110 107 30 34 45 36 8 9 28 36 308 (49.0) 320
3-3 3 6 5 5 1 4 7 6 1 2 3 3 0 1 6 8 26 (42.6) 35 .008
NOTE.—See footnotes to table 3.
4). At this stage of the analysis, it appears that the other
common haplotypes show close to 50%, or “neutral,”
transmission. Interestingly, there is evidence for a rare
(frequency 2%–3%) haplotype (3-3) that may be posi-
tively transmitted or predisposing (table 5).
We also note that the TDT P values for the trans-
mission of the disease-associated alleles and haplotypes
are almost identical to the P values for the modified TDT
statistic, Tsp (Martin et al. 1997), which takes into ac-
count the presence of increased allele sharing in sib pairs
and which allows the data from the second sib to be
included, thereby giving a completely valid and powerful
test of association. For example, the 3-2 haplotype TDT
P value for 2,042 families was .002, and the Tsp P was
.002. Hence, even though the 2,042 families include 707
affected-sib-pair families, which show evidence of allele
sharing and linkage (fig. 1), TDT of all sibs in these
families gives results identical or nearly identical to those
from a valid test of allelic association or linkage dise-
quilibrium, such as the Tsp statistic. This is because the
degree of increased allele sharing in the 707 unrelated
affected sib pairs is very modest and does not introduce
any significant bias into the TDT of all siblings. If our
study had used a few large multigeneration families and
if there had been pronounced allele sharing, then the Tsp
P values would be expected to be much larger than those
from the TDT using all sibs in the analysis. We rec-
ommend, in the analysis of numerous unrelated, af-
fected-sib-pair families, the use of a Tsp-like test as a
valid test of association, rather than the use of TDT and
one affected sibling per family, which is less powerful.
Having shown, by means of the Tsp statistic, evidence of
true association, we find that it is both (1) still convenient
to calculate TDT values and (2) more powerful, in our
current data set, to use TDT data in tests of heteroge-
neity, between affected and unaffected offspring, of
transmission frequencies that are clearly underpinned by
the association of the region with disease.
We now have to extend the physical and genetic maps
flanking the D11S1917-H0570polyA region, to deter-
mine both how much of the chromosome is associated
with type 1 diabetes and whether this is the only region,
under the linkage curve, that shows association with the
disease. It is conceivable that the evidence of linkage is
due to more than one susceptibility locus, as we have
found to be the case in the NOD mouse and its congenic
derivatives: the Idd3 locus on chromosome 3, originally
defined as one peak of linkage (Todd et al. 1991), is now
known to comprise four separate loci (Idd3, Idd10,
Idd17, and Idd18), all within a 30-cM region of chro-
mosome 3 (Podolin et al. 1997, 1998). Therefore, the
entire 15-cM region of linkage on 11q13 must be
scanned more comprehensively by analysis of more
markers in more families, in a search for other regions
of potential association. The results presented here and
elsewhere (Merriman et al. 1997, 1998) clearly show
that moderately polymorphic microsatellites are useful
markers for defining the association of a chromosome
region with disease, even for disease chromosomes that
are common throughout Europe and that are, therefore,
presumably ancient.
Given both the necessary scale of these studies and
the likelihood of complex association-mapping data, it
is essential to evaluate the disease association of func-
tional candidate genes positioned in the region of as-
sociation. We have shown that the H0570polyA locus
is only 3 kb 5′ of a novel gene, designated “LRP5.”
LRP5 is a member of the LDL-receptor gene family and
is both a positional and functional candidate gene for
type 1 diabetes (Hey et al., in press). Future experiments
will include identification of polymorphisms in or near
this gene and of others in the region that have effects
Nakagawa et al.: Chromosome 11q13 Diabetes Locus 555
on this gene’s structure or expression and that could
account for the transmission patterns of the haplotypes
that we have reported here.
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